Investing-News.Com
Information for Investors

GENENTECH INC, (DNA) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

GENENTECH INC, (DNA) Stock Research Free Stock Rating

 
Company Profile
 
Genentech, Inc., a biotechnology company, engages in the discovery, development, manufacture, and commercialization of biotherapeutics for medical needs. It manufactures and commercializes multiple products for a variety of medical conditions, including cancer, heart attack, allergic asthma, psoriasis, stroke, growth hormone deficiency, and cystic fibrosis in the United States. The company’s product portfolio comprises Rituxan, an anti-CD20 antibody; Herceptin, an anti-HER2 antibody; Nutropin Depot growth hormone; Nutropin growth hormone; Protropin growth hormone; Nutropin AQ, a liquid formulation growth hormone; TNKase, a thrombolytic agent; Activase, a tissue plasminogen activator; Cathflo Activase; Pulmozyme, an inhalation solution; Xolair, an anti-IgE antibody; Raptiva, an anti-CD11a antibody; and Avastin, a humanized antibody. It also licenses various additional products to other companies. Genentech’s products under development cover various medical conditions, including cancer, respiratory disorders, cardiovascular diseases, endocrine disorders, and inflammatory and immune problems. In addition, the company, jointly with Rinat Neuroscience Corp., develops RI 624, a humanized monoclonal antibody that blocks nerve growth factor. The company’s products are sold primarily to wholesalers, specialty distributors, or directly to hospital pharmacies. Genentech was founded in 1976 by Robert A. Swanson and Herbert W. Boyer. The company is headquartered in South San Francisco, California.

GENENTECH INC Related

Genentech Discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs.
Genentech: Careers In January 2008, FORTUNE named Genentech to its annual list of ... Opportunities for Recent Graduates. Privacy Policy | Terms & Conditions © Genentech, Inc. ...
Genentech - Wikipedia, the free encyclopedia ... the free encyclopedia. Jump to: navigation, search. Genentech, Inc. ... Genentech Inc. ... "Genentech Inc. - Google Finance". Retrieved on 2008-05-05. ...
Sponsored Links:

Software Forces GENENTECH INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in GENENTECH INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on GENENTECH INC. This software is specially designed to give precision entry and exit points on GENENTECH INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When GENENTECH INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even GENENTECH INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: uk economic data thru 15 jul  seborrheic dermatics  lg lw60 cnt review  comtex news and rumors 2005  hcbk closing data 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

3 Smart Stock Strategies for Right Now (at Motley Fool)

Early Glance: Biotechnology companies (AP)

Prospects of $45 bln loan for Roche receding (Reuters)

RLPC-DEALTALK-Prospects of $45 bln loan for Roche receding (at Reuters)

[$$] Charting The Market (at Barron's Online)

A Giving Strategy for Penny Pinchers (at Motley Fool)

Final Glance: Biotechnology companies (AP)

Midday Glance: Biotechnology companies (AP)

5-Star Stocks Poised to Pop: Novartis (at Motley Fool)

Early Glance: Biotechnology companies (AP)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.